[Estrogen agonists, especially raloxifene, in the treatment of osteoporosis].
Lips
P
P
Academisch Ziekenhuis Vrije Universiteit, afd. Endocrinologie, Amsterdam.
Netelenbos
J C
JC
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects; D001940:Breast / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004717:Endometrium / Q000187:drug effects; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011446:Prospective Studies; D020849:Raloxifene Hydrochloride
D004965:Estrogen Antagonists; D010880:Piperidines; D020849:Raloxifene Hydrochloride
Oestrogeenagonisten, in het bijzonder raloxifen, bij de behandeling van osteoporose.